InvestorsHub Logo
Followers 47
Posts 696
Boards Moderated 0
Alias Born 05/12/2017

Re: VikingInvest post# 402076

Tuesday, 09/14/2021 5:04:16 PM

Tuesday, September 14, 2021 5:04:16 PM

Post# of 699757

The fact that DI mentioned that TLD had no influence on approval timeline makes me believe they actually are well into approval process.


I really don't get people insisting that failing to release TLD is somehow impacting patients. If anything, it is helping patients. Until approval, patients are going to have a difficult time getting DC-Vax. Until manufacturing is increased, only a very limited pool of patients can get DC-Vax. Manufacturing and Regulatory Approval are on the critical path toward treating patients, not the release of TLD. Waiting to release TLD until you can reliably educate the public and medical community about the benefits of DC-Vax will have a far greater impact on its post-approval acceptance and use than releasing TLD early so that impatient shareholders can make money and ditch.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News